In vitro anti‐LPS dose determination of ketorolac tromethamine and in vivo safety of repeated dosing in healthy horses          下载免费PDF全文

A. W. Bianco  G. E. Moore  B. R. Cooper  S. D. Taylor 《Journal of veterinary pharmacology and therapeutics》2018,41(1):98-104

Flunixin meglumine (FM) is a commonly used Nonsteroidal anti‐inflammatory drug (NSAID) in horses, but clinical efficacy is often unsatisfactory. Ketorolac tromethamine (KT) demonstrates superior efficacy compared to other NSAIDs in humans, but its anti‐inflammatory effects have not been investigated in the horse. Safety of repeated dosing of KT has not been evaluated. The first objective was to conduct a dose determination study to verify that a previously described dosage of KT would inhibit Lipopolysaccharide (LPS)‐induced eicosanoid production in vitro, and to compare KT effects of this inhibition to those of FM. Then, a randomized crossover study was performed using nine healthy horses to evaluate plasma concentrations of KT and FM following IV administration. Administered dosages of KT and FM were 0.5 mg/kg and 1.1 mg/kg, respectively. Safety following six repeated doses of KT was assessed. Ketorolac tromethamine and FM suppressed LPS‐induced Thromboxane B₂ (TXB₂) and Prostaglandin E₂ (PGE₂) production in vitro for up to 12 hr. Intravenous administration produced plasma concentrations of KT and FM similar to previous reports. No adverse effects were observed. A KT dosage of 0.5 mg/kg IV inhibited LPS‐induced eicosanoids in vitro, and repeated dosing for up to 3 days appears safe in healthy horses. Investigation of in vivo anti‐inflammatory and analgesic effects of KT is warranted.  相似文献   

Use of fresh vegetable discards as sea urchin diet: effect on gonad index and quality     

Salvatrice Vizzini  Luca Miccichè  Antonino Vaccaro  Antonio Mazzola 《Aquaculture International》2015,23(1):127-139

  相似文献   

Treatment of severe immune-mediated thrombocytopenia with human IV immunoglobulin in 5 dogs     

Bianco D  Armstrong PJ  Washabau RJ 《Journal of veterinary internal medicine / American College of Veterinary Internal Medicine》2007,21(4):694-699

BACKGROUND: Glucocorticoids with or without other immunotherapy are the initial treatment of choice for dogs with severe immune-mediated thrombocytopenia (IMT). The majority of treated dogs will have improvements in platelet counts within 5 to 7 days of starting therapy, but complications from hemorrhage often occur before a response is seen. Human IV immunoglobulin (hIVIG) blocks Fc receptors on mononuclear phagocytic cells in dogs; it is used in people with idiopathic thrombocytopenic purpura. HYPOTHESIS: The purpose of this study was to describe adverse effects and benefit of hIVIG in addition to conventional immunosuppressive therapy in dogs with severe IMT. ANIMALS: Five client-owned dogs with severe primary IMT. METHODS: Case series. The hospital database was searched for dogs with primary IMT treated with hIVIG. RESULTS: No adverse effects were noted during or after hIVIG infusion in any treated dog. Over a 6-month follow-up, all dogs were clinically normal when using conventional immunosuppressive therapy. Human IVIG was administered 3 days after initiation of immunosuppressive therapy in 4 dogs, and, after 2 days, in 1 dog. In all dogs, the mean platelet counts pre- and 24 hours post-hIVIG infusion (0.28-0.76 g/kg) were 2,500/pL and 50,600/microL (62,750/microL for the 4 responders), respectively. One dog failed to respond as promptly to hIVIG (0.34 g/kg), and the platelet count increased to 66,000/microL after 9 days of immunosuppressive therapy. The mean duration of hospitalization post-hIVIG in all 5 dogs was 1.8 days (12 hours for responders), and the mean total length of hospitalization was 4.6 days (3.5 days for responders). Active hemorrhage resolved and no packed red blood cell transfusions were required after hIVIG infusion for responders. CONCLUSIONS AND CLINICAL IMPORTANCE: Human IVIG was well tolerated and appeared to be associated with rapid platelet count recovery and amelioration of clinical signs in most dogs with IMT.  相似文献   

Abstracts of papers presented at the 9th meeting of the international council for the study of viruses and virus diseases of the grapevine     

William B. Hewitt  Marc Fuchs  Bernard Walter  Monique Pinck  Lothaire Pinck  G. Belli  P. A. Bianco  A. Fortusini  Giovanni Granata  Anna Appiano  et al. 《Phytoparasitica》1989,17(1):57-78

  相似文献   

Use of enoxaparin in dogs with primary immune‐mediated hemolytic anemia: 21 cases          下载免费PDF全文

Cynthia M. Panek DVM  Reid K. Nakamura DVM  DACVECC  Domenico Bianco DVM  PhD  DACVIM 《Journal of Veterinary Emergency and Critical Care》2015,25(2):273-277

  相似文献   

Influence of phosphorus fertilization on the response of pinus genotypes to glyphosate subdoses     

de Andrade  Thiago Cavalcante Gomes Ribeiro  Bacha  Allan Lopes  de Camargo  Mariane Bueno  de Carvalho  Leonardo Bianco 《New Forests》2022,53(1):143-160

New Forests - Previous studies have reported that phosphorus transporters are involved in glyphosate uptake by plants, so phosphorus fertilization might act as an attenuator of glyphosate effects...  相似文献   

Transient Fanconi syndrome in Quarter horses     

Cameon M. Ohmes  Elizabeth G. Davis  Laurie A. Beard  Karie A. Vander Werf  Alex W. Bianco  Urs Giger 《The Canadian veterinary journal. La revue veterinaire canadienne》2014,55(2):147-151

Two Quarter horses with weight loss had glucosuria, euglycemia, and a mild metabolic acidosis suggesting a proximal renal tubular defect. Further testing revealed transient generalized aminoaciduria, lactic aciduria, and glucosuria, indicating Fanconi syndrome. Both horses recovered with supportive therapy. This is the first report of acquired Fanconi syndrome in horses.  相似文献   

A retrospective evaluation of doxorubicin‐based chemotherapy for dogs with right atrial masses and pericardial effusion     

S. Ghaffari  D. C. Pelio  A. J. Lange  J. W. Arndt  J. D. Chretin  S. C. Fiocchi  D. Bianco  R. K. Nakamura 《The Journal of small animal practice》2014,55(5):254-257

  相似文献   

Completeness of the dog registry and estimation of the dog population size in a densely populated area of Rome     

Antonino Caminiti  Marcello Sala  Valentina Panetta  Sabrina Battisti  Roberta Meoli  Pasquale Rombolà  Valentina Spallucci  Claudia Eleni  Paola Scaramozzino 《Preventive veterinary medicine》2014

In most European countries, registration and identification of dogs is compulsory. In Italy, the national dog registry is composed of regional dog registries. Although dog registries have been established for many years, the issue related to completeness of data has not been addressed so far. The objective of this study was twofold: first to assess the completeness of data of the dog registry through telephone interview of a sample of dog owners drawn from the dog registry, then to estimate the total owned dog population in 4 boroughs of Rome. For the second objective, a capture–recapture method was applied using data from the dog registry and data from a face-to-face questionnaire submitted to people waiting in the sitting room of 5 points of access for booking and payment of primary and specialist care. Different scenarios are proposed to verify the assumptions of the estimation procedure and potential biases are discussed. The completeness of data of the dog registry was 88.9% (95% CI: 85.8–91.9%) and the owned-dog population was estimated at 26,244 dogs (95% CI: 24,110–28,383). The dog registry is an important source of information especially when it is properly updated and completeness of data is known.  相似文献   

Theta-bearing and complement-receptor lymphocytes are distinct populations of cells   总被引：27，自引：0，他引：27  

C Bianco  V Nussenzweig 《Science (New York, N.Y.)》1971,173(992):154-156

In the mouse, most (or all) complement-receptor lymphocytes and theta-bearing lymphocytes are part of nonoverlapping populations of cells. This finding validates the use of these membrane markers to characterize populations of lymphocytes. In addition, it is probable that, although receptors for complement and membrane-bound immunoglobulins coexist on the same lymphoid cells, these markers are located at separate sites on the membrane.  相似文献